33 institutions hold shares in Cocrystal Pharma Inc. (COCP), with 19.91M shares held by insiders accounting for 27.86% while institutional investors hold 19.75% of the company’s shares. The shares outstanding are 69.39M, and float is at 48.65M with Short Float at 4.65%. Institutions hold 14.25% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Renaissance Technologies, LLC with over 3.95 million shares valued at $5.37 million. The investor’s holdings represent 13.20% of the COCP Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 1.96 million shares valued at $2.66 million to account for 6.54% of the shares outstanding. The other top investors are Blackrock Inc. which holds 1.11 million shares representing 3.70% and valued at over $1.51 million, while Point72 Asset Management, L.P. holds 3.34% of the shares totaling 1.0 million with a market value of $1.36 million.
Cocrystal Pharma Inc. (NASDAQ: COCP) is 8.09% higher on its value in year-to-date trading and has touched a low of $0.70 and a high of $3.04 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The COCP stock was last observed hovering at around $1.37 in the last trading session, with the day’s gains setting it 0.1% off its average median price target of $4.00 for the next 12 months. It is also 63.25% off the consensus price target high of $4.00 offered by 1 analysts, but current levels are 63.25% higher than the price target low of $4.00 for the same period.
Currently trading at $1.47, the stock is -0.94% and -12.49% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.09 million and changing 7.30% at the moment leaves the stock 1.23% off its SMA200. COCP registered 101.37% gain for a year compared to 6-month gain of 59.09%. The firm has a 50-day simple moving average (SMA 50) of $1.5818 and a 200-day simple moving average (SMA200) of $1.3877.
The stock witnessed a 5.76% loss in the last 1 month and extending the period to 3 months gives it a 2.80%, and is 8.89% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.57% over the week and 9.95% over the month.
Cocrystal Pharma Inc. (COCP) has around 13 employees, a market worth around $102.08M and $2.00M in sales. Distance from 52-week low is 109.94% and -51.64% from its 52-week high. The company has generated returns on investments over the last 12 months (-18.30%).
Cocrystal Pharma Inc. (COCP) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Cocrystal Pharma Inc. (COCP) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Cocrystal Pharma Inc. is expected to release its quarterly report on 08/12/2021 and quarterly earnings per share for the current quarter are estimated at -$0.04 with sales reaching $600k over the same period.The EPS is expected to grow by 88.40% this year, but quarterly earnings will post 19.20% year-over-year.
Cocrystal Pharma Inc. (COCP) Insider Activity
A total of 0 insider transactions have happened at Cocrystal Pharma Inc. (COCP) in the last six months, with sales accounting for 0 and purchases happening 0 times.